Zyloprim

Zyloprim brand allopurinol (see also ZYLORIC - WF/M/PL/434). It is intended for the treatment of gout; uric acid nephropathy; recurrent uric acid stone formation; prophylactic treatment to prevent tissue urate deposition, renal calculi or uric acid nephropathy. Supplied in 100 mg., branded U4A and scored tables, bottles of 100 and 500.

Folder 1 includes Zyloprim material from the U.K; brochures on the products use in the treatment of gouty arthritis and other diseases.

Folder 2 includes Zyloprim USA material dated from 1974 -1976, bundled by year. Information includes brochures and advertising (such as gout and dosage cards) directed at the consumer.

Folder 3 includes Zyloprim USA material dated from 1977 -1980, bundled by year. Information includes brochures and advertising (such as gout) directed at the consumer.

Folder 4 includes Zyloprim USA material dated from 1981 -1983, bundled by year. Information includes brochures and advertising (such as gout) directed at the consumer.

Folder 5 includes Zyloprim undated material USA such as pamphlets on urates, nephropathy and gout.

Folder 6 includes Zyloprim overseas material not USA. Material from Canada and Japan?

Folder 7 includes Zyloprim overseas material not USA. Material from Spain? and the Philippines.

c.1974 -c.1983

7 Items

Copyright assigned to the Wellcome Trust